Insmed (INSM) PT Lowered to $195 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Joseph P. Schwartz lowered the price target on Insmed (NASDAQ: INSM) to $195.00 (from $227.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
